cDNA analysis of gene expression associated with DNA-dependent protein kinase activity

International Journal of Oncology

Volumn 30, Issue 2, 2007, Pages 413-420

  Sakata, Koh Ichi ^a   Yamamoto, Hiroyuki ^a   Matsumoto, Yoshihisa ^b   Someya, Masanori ^a   Hareyama, Masato ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

cDNA array; Cell cycle; DNA dependent protein kinase; E2F

Indexed keywords

CELL NUCLEUS ANTIGEN; COMPLEMENTARY DNA; DNA BINDING PROTEIN; DNA DEPENDENT PROTEIN KINASE; KU ANTIGEN; TRANSCRIPTION FACTOR E2F;

ARTICLE; BINDING SITE; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; CELL CYCLE; CLUSTER ANALYSIS; DOUBLE STRANDED DNA BREAK; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; METHODOLOGY; NEOPLASM; PROTEIN BINDING;

ANTIGENS, NUCLEAR; BINDING SITES; CASE-CONTROL STUDIES; CELL CYCLE; CLUSTER ANALYSIS; DNA BREAKS, DOUBLE-STRANDED; DNA, COMPLEMENTARY; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; PROTEIN BINDING;

EID: 34047261275     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bryant PE: Enzymatic restriction of mammalian cell DNA: evidence for double-strand breaks as potentially lethal lesions. Int J Radiat Biol Relat Stud Phys Chem Med 48: 55-60, 1985.
2. Sachs RK, Chen AM and Brenner DJ: Review: proximity effects in the production of chromosome aberrations by ionizing radiation. Int J Radiat Biol 71: 1-19, 1997.
3. Ferguson DO, Sekiguchi JM, Chang S, et al: The non-homologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations. Proc Natl Acad Sci USA 97: 6630-6633, 2000.
4. Lees-Miller SP: The DNA-dependent protein kinase, DNA-PK: 10 years and no ends in sight. Biochem Cell Biol 74: 503-512, 1996.
5. Jeggo PA: Identification of genes involved in repair of DNA double-strand breaks in mammalian cells. Radiat Res 150: S80-S91, 1998.
6. Difilippantonio MJ, Zhu J, Chen HT, et al: DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 404: 510-514, 2000.
7. Karanjawala ZE, Grawunder U, Hsieh CL and Lieber MR: The non-homologous DNA end joining pathway is important for chromosome stability in primary fibroblasts. Curr Biol 9: 1501-1504, 1999.
8. Someya M, Sakata K, Matsumoto Y, et al: The association of DNA-dependent protein kinase activity with chromosomal instability and risk of cancer. Carcinogenesis 27: 117-122, 2006.
9. Heinemeyer T, Wingender E, Reuter I, et al: Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 26: 362-367, 1998.
10. Bracken AP, Ciro M, Cocito A and Helin K: E2F target genes: unraveling the biology. Trends Biochem Sci 29: 409-417, 2004.
11. Dimova DK and Dyson NJ: The E2F transcriptional network: old acquaintances with new faces. Oncogene 24: 2810-2826, 2005.
12. Ishida S, Huang E, Zuzan H, et al: Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol Cell Biol 21: 4684-4699, 2001. (Pubitemid 32588250)
13. Muller H, Bracken AP, Vernell R, et al: E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev 15: 267-285, 2001. (Pubitemid 32155143)
14. Polager S, Kalma Y, Berkovich E and Ginsberg D: E2Fs upregulate expression of genes involved in DNA replication, DNA repair and mitosis. Oncogene 21: 437-446, 2002.
15. Ren B, Cam H, Takahashi Y, et al: E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev 16: 245-256, 2002. (Pubitemid 34075816)
16. Stanelle J, Stiewe T, Theseling CC, Peter M and Putzer BM: Gene expression changes in response to E2F1 activation. Nucleic Acids Res 30: 1859-1867, 2002.
17. Vernell R, Helin K and Muller H: Identification of target genes of the p16INK4A-pRB-E2F pathway. J Biol Chem 278: 46124-46137, 2003.
18. Weinmann AS, Bartley SM, Zhang T, Zhang MQ and Farnham PJ: Use of chromatin immunoprecipitation to clone novel E2F target promoters. Mol Cell Biol 21: 6820-6832, 2001.
19. Young AP, Nagarajan R and Longmore GD: Mechanisms of transcriptional regulation by Rb-E2F segregate by biological pathway. Oncogene 22: 7209-7217, 2003.
20. Eriksson A, Lewensohn R and Nilsson A: Expression and activity of DNA-dependent protein kinase in normal human leukocytes. Anticancer Res 20: 3051-3058, 2000.
21. Grana X, Garriga J and Mayol X: Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth. Oncogene 17: 3365-3383, 1998.
22. Slansky JE and Farnham PJ: Introduction to the E2F family: protein structure and gene regulation. Curr Top Microbiol Immunol 208: 1-30, 1996.
23. Mayol X, Garriga J and Grana X: Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130. Oncogene 11: 801-808, 1995.
24. Mayol X, Garriga J and Grana X: G1 cyclin/CDK-independent phosphorylation and accumulation of p130 during the transition from G1 to G0 lead to its association with E2F-4. Oncogene 13: 237-246, 1996. (Pubitemid 26334855)
25. Yaneva M and Jhiang S: Expression of the Ku protein during cell proliferation. Biochim Biophys Acta 2: 181-187, 1991.
26. Karlseder J, Rotheneder H and Wintersberger E: Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F. Mol Cell Biol 16: 1659-1667, 1996.
27. Vogt B, Zerfass-Thome K, Schulze A, Botz JW, Zwerschke W and Jansen-Durr P: Regulation of cyclin E gene expression by the human papillomavirus type 16 E7 oncoprotein. J Gen Virol 80: 2103-2113, 1999. (Pubitemid 29389148)
28. Bartek J and Lukas J: Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3: 421-429, 2003.
29. Motoyama N and Naka K: DNA damage tumor suppressor genes and genomic instability. Curr Opin Genet Dev 14: 11-16, 2004.